RYTM
RYTM
NASDAQ · Biotechnology

Rhythm Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$98.04
-1.23 (-1.24%)
As of Sep 23, 7:50 PM ET ·
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Buy 20 87%
Hold 3 13%
Sell 0 0%
Price Target
Analyst Price Target +3.1% upside
Low Target $80.78
Average Target $101.09
High Target $123.16
Current Price $98.04
Current
$98.04
Target
$101.09
$80.78 $101.09 avg $123.16
Scenario Analysis
Bear Case
$80.78
-17.6%
Low target
Base Case
$101.09
+3.1%
Avg target
Bull Case
$123.16
+25.6%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$122.20
-19.8% from high
52-Week Low
$74.50
+31.6% from low
50-Day SMA
$105.86
-7.4% vs SMA
200-Day SMA
$92.90
+5.5% vs SMA
RSI (14)
49.1
Neutral
Target vs 52W High
$101.09
-17.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.8%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.0%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +141.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.8%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.3%